Cavan John T

Avg. Two Year Performance

(63%) Avg. Purchase Return
(28%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(8%)(15%)(28%)(46%)(63%)
Purchase Success Rate0 of 20 of 20 of 20 of 20 of 2
Average Sale Return----------
Sale Success Rate----------
Drugs » Drug Manufacturers - Major

VP & Chief Accounting Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Financial Officer:

Holdings: 14.8K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--